Jörg B.
- Country
- Germany
- Department
- Neurologie
Research Overview
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
- BRIGHT - A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in Subjects with Acute Ischemic Stroke (AIS)
Data & Insights
Has run more than one trial at 432 of 1084 partner sites.
Specializations
Cardiovascular Disorders
The investigator specializes in atrial fibrillation research, with particular emphasis on preventing cardioembolic events and managing stroke risk in cardiac patients. Their work involves evaluating novel therapeutic approaches for patients unsuitable for conventional anticoagulation treatments.
- Atrial Fibrillation Management
- Cardioembolic Event Prevention
- Alternative Anticoagulation Strategies
Their research extends to exploring innovative anticoagulant therapies and their effectiveness in preventing stroke complications.
Neurodegenerative Conditions
The investigator focuses on Alzheimer's Disease research, particularly studying interventions for mild cognitive impairment and early-stage dementia. Their work encompasses evaluating therapeutic responses in patients aged 50 to 80 years.
- Mild Cognitive Impairment
- Early-Stage Alzheimer's Disease
- Cognitive Function Assessment
Their investigations concentrate on developing treatments that may improve cognitive symptoms and slow disease progression.
Cerebrovascular Disorders
The investigator specializes in treating acute ischemic stroke and high-risk transient ischemic attacks. Their research encompasses both immediate intervention strategies and preventive approaches for stroke management.
- Acute Stroke Treatment
- Stroke Prevention
- Post-Stroke Care
Their work involves evaluating novel therapeutic compounds for improving outcomes in acute stroke patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.